CDTX logo

Cidara Therapeutics (CDTX) Long Term Liabilities

Annual Total Long Term Liabilities

$7.82 M
-$12.70 M-61.89%

31 December 2023

CDTX Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Long Term Liabilities

$2.36 M
-$416.00 K-14.97%

30 September 2024

CDTX Quarterly Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CDTX Long Term Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-61.9%-88.1%
3 y3 years-29.8%-87.5%
5 y5 years+9556.8%+104.5%

CDTX Long Term Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-61.9%at low-90.5%at low
5 y5 years-61.9%+9556.8%-90.5%+864.1%
alltimeall time-76.0%+9556.8%-96.8%+8335.7%

Cidara Therapeutics Long Term Liabilities History

DateAnnualQuarterly
Sept 2024
-
$2.36 M(-15.0%)
June 2024
-
$2.78 M(-45.2%)
Mar 2024
-
$5.07 M(-35.2%)
Dec 2023
$7.82 M(-61.9%)
$7.82 M(-60.5%)
Sept 2023
-
$19.81 M(-6.3%)
June 2023
-
$21.15 M(+10.0%)
Mar 2023
-
$19.24 M(-6.3%)
Dec 2022
$20.52 M(+4.0%)
$20.52 M(-17.0%)
Sept 2022
-
$24.74 M(+54.3%)
June 2022
-
$16.03 M(-12.1%)
Mar 2022
-
$18.23 M(-7.6%)
Dec 2021
$19.73 M(+77.1%)
$19.73 M(+4.6%)
Sept 2021
-
$18.87 M(+34.2%)
June 2021
-
$14.07 M(+13.9%)
Mar 2021
-
$12.35 M(+10.8%)
Dec 2020
$11.14 M(+1083.1%)
$11.14 M(+4449.0%)
Sept 2020
-
$245.00 K(-49.4%)
June 2020
-
$484.00 K(-32.4%)
Mar 2020
-
$716.00 K(-24.0%)
Dec 2019
$942.00 K
$942.00 K(-18.4%)
DateAnnualQuarterly
Sept 2019
-
$1.16 M(-15.2%)
June 2019
-
$1.36 M(-12.4%)
Mar 2019
-
$1.55 M(+1818.5%)
Dec 2018
$81.00 K(-98.9%)
$81.00 K(-99.1%)
Sept 2018
-
$9.31 M(-6.4%)
June 2018
-
$9.95 M(+27.4%)
Mar 2018
-
$7.81 M(+8.4%)
Dec 2017
$7.21 M(-27.0%)
$7.21 M(-12.6%)
Sept 2017
-
$8.25 M(-10.7%)
June 2017
-
$9.24 M(-6.6%)
Mar 2017
-
$9.89 M(+0.1%)
Dec 2016
$9.87 M(>+9900.0%)
$9.87 M(>+9900.0%)
Sept 2016
-
$85.00 K(-5.6%)
June 2016
-
$90.00 K(+1.1%)
Mar 2016
-
$89.00 K(+1.1%)
Dec 2015
$88.00 K(-99.7%)
$88.00 K(0.0%)
Sept 2015
-
$88.00 K(+214.3%)
June 2015
-
$28.00 K(-100.0%)
Mar 2015
-
$74.50 M(+128.7%)
Dec 2014
$32.58 M(+2097.0%)
$32.58 M
Dec 2013
$1.48 M
-

FAQ

  • What is Cidara Therapeutics annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Cidara Therapeutics?
  • What is Cidara Therapeutics annual total long term liabilities year-on-year change?
  • What is Cidara Therapeutics quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Cidara Therapeutics?
  • What is Cidara Therapeutics quarterly long term liabilities year-on-year change?

What is Cidara Therapeutics annual total long term liabilities?

The current annual total long term liabilities of CDTX is $7.82 M

What is the all time high annual total long term liabilities for Cidara Therapeutics?

Cidara Therapeutics all-time high annual total long term liabilities is $32.58 M

What is Cidara Therapeutics annual total long term liabilities year-on-year change?

Over the past year, CDTX annual total long term liabilities has changed by -$12.70 M (-61.89%)

What is Cidara Therapeutics quarterly total long term liabilities?

The current quarterly long term liabilities of CDTX is $2.36 M

What is the all time high quarterly long term liabilities for Cidara Therapeutics?

Cidara Therapeutics all-time high quarterly total long term liabilities is $74.50 M

What is Cidara Therapeutics quarterly long term liabilities year-on-year change?

Over the past year, CDTX quarterly total long term liabilities has changed by -$17.45 M (-88.08%)